CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. Escola Paulista de Medicina (EPM) (Institutional affiliation from the last research proposal) Birthplace: Brazil
bachelor's at Ciências Biológicas - Modalidade Médica from Universidade Federal de São Paulo (1994), master's at Pharmacology from Universidade Federal de São Paulo (1997) and doctorate at Pharmacology from Universidade Federal de São Paulo (2001). Has experience in psychobiology and neuropsychopharmacology, acting on the following subjects: learning and memory, relationship between memory and emotion and animal models for studying central nervous system disorders. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Parkinson's Disease (PD) is a chronic, multifactorial, and pathophysiological neurodegenerative disease characterized by the progressive death of dopaminergic neurons, resulting in motor deficits. Some studies show that noradrenergic pathway dysfunction is associated with non-motor symptoms and disease progression. Besides, these studies also suggest that the nigrostriatal pathway dysfunc…
Parkinson's disease (DP) is the second most prevalent age-related neurodegenerative disorder. PD comprises motor and non-motor symptoms and it's pathophysiology is related to progressive neuronal loss in the substantia nigra pars compacta. There is no known intervention that delays this progression, and at the onset of the motor symptoms, approximately 70% of the neurons have already been…
Parkinson´s disease is the second most prevalent age-related neurodegenerative disorder. The main symptoms of this pathology are severe motor deficits, but non-motor signs are also present. The pathophysiology comprises a progressive neuronal loss, and there is currently no effective intervention for slowing the degeneration. There is evidence of an important role of neuronal oxidative st…
Parkinson's disease (PD) is a motor disorder related to aging that currently affects 1-2% of the population over the age of 60, figuring as the second most common neurodegenerative disorder. Recently, the repeated treatment with low doses of reserpine (0.1 mg/kg, every other day) was validated for progressive neurochemical and behavioral alterations reminiscent of PD. For example, among o…
Parkinson's disease (PD), a chronic progressive neurodegenerative disorder, is associated with degeneration of dopaminergic neurons in substantia nigra pars compacta and striatum. In addition, several studies speculate that oxidative stress take part in reduction of dopamine levels.Although some cases of the disease can be attributed to genetic and environmental influences, the cause of m…
The Parkinson Disease (PD) is characterized as a motor disease related to aging. Nevertheless not being the most frequent neurodegenerative disease, behind only Alzheimer's disease, it currently afflicts 1-2% of the world population above 60 years old. Thus, countries with increasing life expectancy, as Brazil, consider PD an important public health burden. The epidemiology of PD involves…
(Only some records are available in English at this moment)
| 1 / 1 | Ongoing grants |
| 3 / 2 | Completed research grants |
| 5 / 4 | Completed scholarships in Brazil |
| 9 / 7 | All research grants and scholarships |
| Associated processes | |